Related Experiment Video
Updated: Apr 11, 2026

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
Novel heterozygous UCHL1 variant causing severe optic atrophy and vision loss
Natalie S Lee1, Clare L Fraser1,2, Zornitza Stark3,4
1Department of Ophthalmology, Sydney Hospital and Sydney Eye Hospital, Sydney, Australia.
Introduction:
Heterozygous UCHL1 variants have recently been associated with an autosomal dominant neurodegenerative disease characterized by spastic ataxia, optic atrophy and neuropathy.
Methods:
We describe two individuals from a single family who presented with optic atrophy and progressive vision loss, without demonstrable spasticity, ataxia or peripheral neuropathy.
Results:
Genetic testing revealed a novel pathogenic UCHL1 variant accounting for the two individuals' phenotype.
Discussion:
Our findings highlight the significant phenotypic variability related to heterozygous UCHL1-related disease. Clinicians should consider UCHL1 variants in individuals presenting with multigenerational optic atrophy even in the absence of multisystem features.
More Related Videos
10:10Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
Published on: November 2, 2018
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Photoreceptors and Visual Pathways
Genetic Lingo
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment